In this study, FTH1 expression was upregulated in most KRAS-mutant human pancreatic cancer cells and clinical pancreatic cancer tissues, contributing to PDAC progression through positive crosstalk with PYCR1 and promoting proline metabolism dysregulation (Supplementary Fig. 7). This evidence concerns the gene KRAS and pancreatic neoplasm.